Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis
about
sameAs
Proton pump inhibitors in prevention of low-dose aspirin-associated upper gastrointestinal injuriesPeptic ulcer disease todayOptimizing cardiovascular and chemopreventive benefits of aspirin: what role for the proton-pump inhibitors?Interobserver variation in the endoscopic diagnosis of gastroduodenal ulcer scars: implications for clinical management of NSAIDs users.Prevention of chronic NSAID induced upper gastrointestinal toxicity.CYP2C19 pharmacogenomics associated with therapy of Helicobacter pylori infection and gastro-esophageal reflux diseases with a proton pump inhibitor.Improving the gastrointestinal tolerability of aspirin in older people.Management of low-dose aspirin and clopidogrel in clinical practice: a gastrointestinal perspective.Evidence-based clinical practice guidelines for peptic ulcer disease 2015.Healing of gastric ulcers with esomeprazole versus ranitidine in patients who continued to receive NSAID therapy: a randomized trial.Are the Symptoms of an NSAID-Induced Ulcer Truly Milder Than Those of an Ordinary Ulcer?Vonoprazan prevents ulcer recurrence during long-term NSAID therapy: randomised, lansoprazole-controlled non-inferiority and single-blind extension study.[Management of postoperative pain in ear-nose-throat surgery].
P2860
Q27004834-8037EAE0-96A2-4B6A-9F78-4E88A9F4B3B1Q28194844-880A4F04-BB4F-41FA-90C1-F90F2B7F1783Q28218738-935AD3F6-2041-4AD9-9D67-F24B668F178AQ31034785-74C43817-18DB-45F0-9BD8-B2D95CE0CB92Q33978682-18AB8E16-D8E5-49FA-BBD7-47A95A529B96Q34583603-23E7D386-868D-448E-B6B6-BE4732E26C94Q37019062-A54E05F0-E9DC-4A75-9C1D-4181FE2DC904Q38321114-8DD745E1-BA23-4F05-A790-E7300D94CA55Q40790399-3CE9BAF5-FCFA-434E-8705-9A3CDBA13416Q46879529-4A7B47E6-AB9E-47A4-84E5-854B50016F6CQ47149652-CF4D77F0-E30F-4C19-9422-981476473C1AQ49502634-19714106-A29F-46EB-9A24-F6707513A623Q54759381-500138FE-075A-4A7F-83BC-763BAE6AC738
P2860
Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis
description
2004 nî lūn-bûn
@nan
2004 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Ulcer recurrence in high-risk ...... ults of a post HOC subanalysis
@ast
Ulcer recurrence in high-risk ...... ults of a post HOC subanalysis
@en
Ulcer recurrence in high-risk ...... ults of a post HOC subanalysis
@nl
type
label
Ulcer recurrence in high-risk ...... ults of a post HOC subanalysis
@ast
Ulcer recurrence in high-risk ...... ults of a post HOC subanalysis
@en
Ulcer recurrence in high-risk ...... ults of a post HOC subanalysis
@nl
prefLabel
Ulcer recurrence in high-risk ...... ults of a post HOC subanalysis
@ast
Ulcer recurrence in high-risk ...... ults of a post HOC subanalysis
@en
Ulcer recurrence in high-risk ...... ults of a post HOC subanalysis
@nl
P2093
P1476
Ulcer recurrence in high-risk ...... ults of a post HOC subanalysis
@en
P2093
Bidan Huang
Fouad Amer
Jay L Goldstein
Nikos G Christopoulos
P304
P356
10.1016/J.CLINTHERA.2004.10.002
P407
P577
2004-10-01T00:00:00Z